---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-22-001522"
form_type: "8-K"
ticker: "CRDF"
cik: "0001213037"
company_name: "Cardiff Oncology, Inc."
filed_at: "2022-01-31T23:59:59+00:00"
generated_at: "2026-06-27T13:26:19.501407+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Cardiff Oncology grants 55,008 stock options to new employee as inducement

## Summary
- Non-qualified stock options for 55,008 shares granted on Jan 31, 2022 to one new employee.
- Exercise price of $3.38 per share, equal to Jan 31 closing price.
- Options vest over 4 years: 25% at 1-year anniversary, remainder monthly over 36 months.
- Grant made under Nasdaq Listing Rule 5635(c)(4) as inducement material to employment.

## SEC filing metadata
- accession: 0001628280-22-001522
- form_type: 8-K
- ticker: CRDF
- cik: 0001213037
- company_name: Cardiff Oncology, Inc.
- filed_at: 2022-01-31T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1213037/000162828022001522/0001628280-22-001522-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1213037/000162828022001522/crdf-20220131.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-22-001522
- JSON: https://secwatch.observer/filing/0001628280-22-001522.json
- Plain text: https://secwatch.observer/filing/0001628280-22-001522.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.